A Study Of Virtual Reality Vs Sham VR On Fibromyalgia
Running, not enrolling · Not applicable · Has a placebo group
Conditions studied: Fibromyalgia
In brief
The purpose of this study is to understand the therapeutic impact of VR on Fibromyalgia symptoms and potentially increase the scope of treatment options for patients suffering from Fibromyalgia.
Key facts
- Study ID
- NCT07202572
- Run by
- Mayo Clinic
- People needed
- 40
- Starts
- 2025-09-29
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-02-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged >18 years old
- Diagnosis of fibromyalgia based on ACR 2016 criteria
- Stable on current medications and non-pharmacologic treatments for 4 weeks
- Ability and willingness to use a Meta Quest 3 VR headset Fluent in English
- Provide informed consent
You may not qualify if…
- History of seizures or conditions contraindicating VR use
- Severe psychiatric illness (e.g., psychosis)
- Cognitive impairment interfering with study participation
- Participation in other interventional trials
Where it is running
- Mayo Clinic in Florida — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.